- TWD18.31bn
- TWD18.83bn
- TWD19.11bn
- 68
- 64
- 83
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17,081 | 17,484 | 18,646 | 23,043 | 19,113 |
Cost of Revenue | |||||
Gross Profit | 4,541 | 4,704 | 5,215 | 6,495 | 5,200 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 16,203 | 16,522 | 17,501 | 21,043 | 17,786 |
Operating Profit | 879 | 962 | 1,145 | 2,000 | 1,327 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 846 | 851 | 1,155 | 2,144 | 1,381 |
Provision for Income Taxes | |||||
Net Income After Taxes | 681 | 722 | 930 | 1,655 | 1,056 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 675 | 716 | 921 | 1,650 | 1,053 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 675 | 716 | 921 | 1,650 | 1,053 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.62 | 1.74 | 2.09 | 3.99 | 2.51 |
Dividends per Share |